Aveanna Healthcare 3Q 2026: Revenue $695.54M, EPS $0.2 — 10-Q Summary
Aveanna Healthcare reported 3Q 2026 revenue of $695.54M, up 11.8% YoY, and net income of $45.45M, up 223.2% YoY. Growth was driven by all three segments, lower expenses, and improved other income. EPS was $0.2, up 233.3% YoY. Higher tax expense partly offset gains.
How this was made

The 30-second read
Why it matters
The earnings beat provides fresh data for traders to reassess AVAH's valuation and short‑term price direction.
Market read
First public disclosure of Q3 2026 results; material earnings surprise may move the stock in after‑hours and next day trading.
What to watch
Potential headwinds from labor shortages in home health and regulatory changes could temper growth.
Background
The article is an AI‑generated summary of Aveanna Healthcare's 10‑Q filing for Q3 2026.
Ticker impact
Aveanna Healthcare reported Q3 2026 revenue of $695.5M (+11.8% YoY) and net income of $45.5M (+223% YoY) in its 10‑Q filing.
likely upward pressure as market prices in the earnings beat and margin expansion
Revenue and net income both exceeded prior year expectations, margins improved, and segment volumes rose, supporting a bullish short‑term reaction.
Market effects
Healthcare services sector may see modest uplift as Aveanna's growth signals demand strength in home health and private duty services.
U.S. healthcare stocks could experience slight positive bias in early trading.
Limited to U.S. markets; no broader macro impact.
Counterpoint
Despite earnings beat, the company remains small and may face scalability challenges; investors might be cautious on valuation.
Key entities
- companyAveanna Healthcare Holdings, Inc.
U.S. listed home health and hospice provider.
